C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 473/04 (2006.01) A61K 31/52 (2006.01) A61K 31/535 (2006.01) C07D 473/06 (2006.01)
Patent
CA 2218548
1,3-Disubstituted-zanthines have therapeutic utility via TNF or phosphodiesterase inhibition.
Les xanthines 1,3-disubstituées présentent un intérêt thérapeutique, par l'inhibition de la TNF ou de la phosphodiestérase.
Borden Ladner Gervais Llp
Chiroscience Limited
Darwin Discovery Limited
LandOfFree
Xanthines and their therapeutic use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Xanthines and their therapeutic use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xanthines and their therapeutic use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1786680